Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DYNC2H1 DYNC1H1 DNAH14	7.59e-05	18	93	3	GO:0008569
GeneOntologyCellularComponent	lateral element	SYCP2 BRCA1 BRCA2 SYCP1	1.41e-06	19	94	4	GO:0000800
GeneOntologyCellularComponent	synaptonemal complex	SYCP2 BRCA1 BRCA2 SYCP1	5.41e-05	46	94	4	GO:0000795
GeneOntologyCellularComponent	synaptonemal structure	SYCP2 BRCA1 BRCA2 SYCP1	5.41e-05	46	94	4	GO:0099086
GeneOntologyCellularComponent	dynein complex	DNAI1 DYNC2H1 DYNC1H1 DNAH14	1.02e-04	54	94	4	GO:0030286
GeneOntologyCellularComponent	cytoplasmic region	DNAI1 DYNC2H1 PCLO CFAP206 DLG2 RP1 SPAG8 DYNC1H1	2.20e-04	360	94	8	GO:0099568
GeneOntologyCellularComponent	plasma membrane bounded cell projection cytoplasm	DNAI1 DYNC2H1 CFAP206 DLG2 RP1 SPAG8 DYNC1H1	5.72e-04	317	94	7	GO:0032838
GeneOntologyCellularComponent	condensed nuclear chromosome	SYCP2 BRCA1 BRCA2 SYCP1	7.60e-04	91	94	4	GO:0000794
GeneOntologyCellularComponent	microtubule associated complex	DNAI1 DYNC2H1 RP1 DYNC1H1 DNAH14	8.05e-04	161	94	5	GO:0005875
GeneOntologyCellularComponent	nuclear ubiquitin ligase complex	FZR1 BRCA1 BRCA2	1.40e-03	49	94	3	GO:0000152
Domain	Dynein_heavy_chain_D4_dom	DYNC2H1 DYNC1H1 DNAH14	4.32e-05	14	94	3	IPR024317
Domain	Dynein_HC_stalk	DYNC2H1 DYNC1H1 DNAH14	4.32e-05	14	94	3	IPR024743
Domain	MT	DYNC2H1 DYNC1H1 DNAH14	4.32e-05	14	94	3	PF12777
Domain	AAA_8	DYNC2H1 DYNC1H1 DNAH14	4.32e-05	14	94	3	PF12780
Domain	DHC_fam	DYNC2H1 DYNC1H1 DNAH14	5.38e-05	15	94	3	IPR026983
Domain	Dynein_heavy_dom	DYNC2H1 DYNC1H1 DNAH14	5.38e-05	15	94	3	IPR004273
Domain	Dynein_heavy	DYNC2H1 DYNC1H1 DNAH14	5.38e-05	15	94	3	PF03028
Domain	SYCP1/2	SYCP2 SYCP1	7.49e-05	3	94	2	IPR024835
Domain	SH3_9	CASS4 ARHGAP32 SH3D19 NEB	6.46e-04	78	94	4	PF14604
Domain	DHC_N1	DYNC2H1 DYNC1H1	6.88e-04	8	94	2	PF08385
Domain	Dynein_heavy_dom-1	DYNC2H1 DYNC1H1	6.88e-04	8	94	2	IPR013594
Domain	SH3	CASS4 ARHGAP32 MIA3 SH3D19 DLG2 NEB	7.80e-04	216	94	6	SM00326
Domain	SH3	CASS4 ARHGAP32 MIA3 SH3D19 DLG2 NEB	7.80e-04	216	94	6	PS50002
Domain	SH3_domain	CASS4 ARHGAP32 MIA3 SH3D19 DLG2 NEB	8.58e-04	220	94	6	IPR001452
Domain	Chromo_dom_subgr	CDY2A CDY1	1.10e-03	10	94	2	IPR017984
Domain	SH3_1	CASS4 ARHGAP32 SH3D19 DLG2 NEB	1.44e-03	164	94	5	PF00018
Domain	Dynein_heavy_dom-2	DYNC2H1 DYNC1H1	2.19e-03	14	94	2	IPR013602
Domain	DHC_N2	DYNC2H1 DYNC1H1	2.19e-03	14	94	2	PF08393
Domain	ATPase_dyneun-rel_AAA	DYNC2H1 DYNC1H1	2.19e-03	14	94	2	IPR011704
Domain	AAA_5	DYNC2H1 DYNC1H1	2.19e-03	14	94	2	PF07728
Domain	Crotonase_core_superfam	CDY2A CDY1	3.24e-03	17	94	2	IPR001753
Domain	ECH_1	CDY2A CDY1	3.24e-03	17	94	2	PF00378
Domain	G_patch	AGGF1 NKRF	5.92e-03	23	94	2	SM00443
Domain	G_patch_dom	AGGF1 NKRF	5.92e-03	23	94	2	IPR000467
Domain	G_PATCH	AGGF1 NKRF	5.92e-03	23	94	2	PS50174
Domain	G-patch	AGGF1 NKRF	5.92e-03	23	94	2	PF01585
Pubmed	BRCA1-mediated chromatin silencing is limited to oocytes with a small number of asynapsed chromosomes.	SYCP2 BRCA1 SYCP1	1.64e-06	9	95	3	19531582
Pubmed	Multiple roles of FOXJ3 in spermatogenesis: A lesson from Foxj3 conditional knockout mouse models.	SYCP2 BRCA1 BRCA2 SYCP1	1.77e-06	32	95	4	27739607
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	ABCC1 ARHGAP32 TRMT10C MIA3 PPP2R5D MOSPD2 PTPRC KCNMA1 TAB2 PTPN22 MPHOSPH9 GPRIN1 LUZP1	5.63e-06	1049	95	13	27880917
Pubmed	Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.	ARHGAP32 CNOT11 MIA3 NRBF2 ICE2 TAB2 MPHOSPH9	6.04e-06	251	95	7	29778605
Pubmed	Phosphorylation of chromosome core components may serve as axis marks for the status of chromosomal events during mammalian meiosis.	SYCP2 BRCA1 SYCP1	7.03e-06	14	95	3	22346761
Pubmed	Association of BRCA1/2 mutations with ovarian cancer prognosis: An updated meta-analysis.	BRCA1 BRCA2	7.38e-06	2	95	2	29480828
Pubmed	A systematic genetic assessment of 1,433 sequence variants of unknown clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition genes.	BRCA1 BRCA2	7.38e-06	2	95	2	17924331
Pubmed	Attitudes, knowledge, risk perceptions and decision-making among women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2 and their spouses.	BRCA1 BRCA2	7.38e-06	2	95	2	12833555
Pubmed	Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation.	BRCA1 BRCA2	7.38e-06	2	95	2	14735173
Pubmed	Coffee consumption and breast cancer risk among BRCA1 and BRCA2 mutation carriers.	BRCA1 BRCA2	7.38e-06	2	95	2	16032702
Pubmed	Oral contraceptive use and BRCA penetrance: a case-only study.	BRCA1 BRCA2	7.38e-06	2	95	2	19549808
Pubmed	Prevalence of BRCA1 and BRCA2 Mutations Among Patients With Ovarian, Primary Peritoneal, and Fallopian Tube Cancer in India: A Multicenter Cross-Sectional Study.	BRCA1 BRCA2	7.38e-06	2	95	2	34101484
Pubmed	Olaparib monotherapy in patients with advanced relapsed ovarian cancer and a germline BRCA1/2 mutation: a multistudy analysis of response rates and safety.	BRCA1 BRCA2	7.38e-06	2	95	2	26961146
Pubmed	Predicting BRCA1 and BRCA2 gene mutation carriers: comparison of PENN II model to previous study.	BRCA1 BRCA2	7.38e-06	2	95	2	20512419
Pubmed	Deleterious and ethnic-related BRCA1/2 mutations in tissue and blood of Egyptian colorectal cancer patients and its correlation with human papillomavirus.	BRCA1 BRCA2	7.38e-06	2	95	2	37804357
Pubmed	Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.	BRCA1 BRCA2	7.38e-06	2	95	2	22053997
Pubmed	BRCA mutations in women with inflammatory breast cancer.	BRCA1 BRCA2	7.38e-06	2	95	2	29044548
Pubmed	Mutations in BRCA1 and BRCA2 differentially affect the tumor microenvironment and response to checkpoint blockade immunotherapy.	BRCA1 BRCA2	7.38e-06	2	95	2	33834176
Pubmed	Should genetic testing for BRCA1/2 be permitted for minors? Opinions of BRCA mutation carriers and their adult offspring.	BRCA1 BRCA2	7.38e-06	2	95	2	18200524
Pubmed	Enhanced response rate to pegylated liposomal doxorubicin in high grade serous ovarian carcinomas harbouring BRCA1 and BRCA2 aberrations.	BRCA1 BRCA2	7.38e-06	2	95	2	29298688
Pubmed	Fertility in women with BRCA mutations: a case-control study.	BRCA1 BRCA2	7.38e-06	2	95	2	19200971
Pubmed	Prevalence of BRCA mutations and founder effect in high-risk Hispanic families.	BRCA1 BRCA2	7.38e-06	2	95	2	16030099
Pubmed	Prevalence of BRCA1 and BRCA2 large genomic rearrangements in Tunisian high risk breast/ovarian cancer families: Implications for genetic testing.	BRCA1 BRCA2	7.38e-06	2	95	2	28212807
Pubmed	Genetic counseling impacts decision for prophylactic surgery for patients perceived to be at high risk for breast cancer.	BRCA1 BRCA2	7.38e-06	2	95	2	11448436
Pubmed	Rapid evolution of BRCA1 and BRCA2 in humans and other primates.	BRCA1 BRCA2	7.38e-06	2	95	2	25011685
Pubmed	Breast magnetic resonance imaging for screening high-risk women.	BRCA1 BRCA2	7.38e-06	2	95	2	23928241
Pubmed	Heterozygous BRCA1 and BRCA2 and Mismatch Repair Gene Pathogenic Variants in Children and Adolescents With Cancer.	BRCA1 BRCA2	7.38e-06	2	95	2	35980168
Pubmed	Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study.	BRCA1 BRCA2	7.38e-06	2	95	2	11377596
Pubmed	BRCA mutations and risk of prostate cancer in Ashkenazi Jews.	BRCA1 BRCA2	7.38e-06	2	95	2	15131025
Pubmed	Broad BRCA1 and BRCA2 mutational spectrum and high incidence of recurrent and novel mutations in the eastern Spain population.	BRCA1 BRCA2	7.38e-06	2	95	2	20033483
Pubmed	Health survey and assessment of the polymorphisms BRCA1/P871L, BRCA1/Q356R, and BRCA2/N372H in female gas station workers in Rio de Janeiro.	BRCA1 BRCA2	7.38e-06	2	95	2	28862356
Pubmed	BRCA1 and BRCA2 germline mutations in Moroccan breast/ovarian cancer families: novel mutations and unclassified variants.	BRCA1 BRCA2	7.38e-06	2	95	2	22425665
Pubmed	BRCA1/2 in high-risk African American women with breast cancer: providing genetic testing through various recruitment strategies.	BRCA1 BRCA2	7.38e-06	2	95	2	18752448
Pubmed	Peritoneal washing cytology in patients with BRCA1 or BRCA2 mutations undergoing risk-reducing salpingo-oophorectomies: a 10-year experience and reappraisal of its clinical utility.	BRCA1 BRCA2	7.38e-06	2	95	2	22425664
Pubmed	Identification of BRCA1/2 founder mutations in Southern Chinese breast cancer patients using gene sequencing and high resolution DNA melting analysis.	BRCA1 BRCA2	7.38e-06	2	95	2	22970155
Pubmed	Anti-müllerian hormone levels and antral follicle count in women with a BRCA1 or BRCA2 germline pathogenic variant: A retrospective cohort study.	BRCA1 BRCA2	7.38e-06	2	95	2	34304065
Pubmed	Absence of 185delAG and 6174delT Mutations among Breast Cancer Patients of Eastern India.	BRCA1 BRCA2	7.38e-06	2	95	2	26625823
Pubmed	Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancer.	BRCA1 BRCA2	7.38e-06	2	95	2	26852015
Pubmed	Meta-analysis of BRCA1 and BRCA2 penetrance.	BRCA1 BRCA2	7.38e-06	2	95	2	17416853
Pubmed	Power spectral analysis of mammographic parenchymal patterns for breast cancer risk assessment.	BRCA1 BRCA2	7.38e-06	2	95	2	18175183
Pubmed	Presence of crown-like structures in breast adipose tissue; differences between healthy controls, BRCA1/2 gene mutation carriers and breast cancer patients.	BRCA1 BRCA2	7.38e-06	2	95	2	38057686
Pubmed	Germline mutations in BRCA1 and BRCA2 in epithelial ovarian cancer patients in Brazil.	BRCA1 BRCA2	7.38e-06	2	95	2	27914478
Pubmed	BRCA1 and BRCA2 germline mutations in Korean breast cancer patients at high risk of carrying mutations.	BRCA1 BRCA2	7.38e-06	2	95	2	16455195
Pubmed	The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial.	BRCA1 BRCA2	7.38e-06	2	95	2	23810788
Pubmed	Prognostic Impact of Breast-Conserving Therapy Versus Mastectomy of BRCA1/2 Mutation Carriers Compared With Noncarriers in a Consecutive Series of Young Breast Cancer Patients.	BRCA1 BRCA2	7.38e-06	2	95	2	29727326
Pubmed	Risk reducing surgery with peritoneal staging in BRCA1-2 mutation carriers. A prospective study.	BRCA1 BRCA2	7.38e-06	2	95	2	35871032
Pubmed	Recurrent BRCA1 and BRCA2 mutations in breast cancer patients of African ancestry.	BRCA1 BRCA2	7.38e-06	2	95	2	22739995
Pubmed	The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case-control study.	BRCA1 BRCA2	7.38e-06	2	95	2	27794048
Pubmed	Breast cancer surgery trend changes since the introduction of BRCA1/2 mutation screening: a retrospective cohort analysis of 158 mutation carriers treated at a single institution.	BRCA1 BRCA2	7.38e-06	2	95	2	20972632
Pubmed	BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients.	BRCA1 BRCA2	7.38e-06	2	95	2	19499246
Pubmed	Comprehensive mutational analysis of BRCA1/BRCA2 for Korean breast cancer patients: evidence of a founder mutation.	BRCA1 BRCA2	7.38e-06	2	95	2	19656164
Pubmed	Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers.	BRCA1 BRCA2	7.38e-06	2	95	2	15986445
Pubmed	Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer.	BRCA1 BRCA2	7.38e-06	2	95	2	18165636
Pubmed	Large genomic rearrangements in BRCA1 and BRCA2: implications for patient care.	BRCA1 BRCA2	7.38e-06	2	95	2	23615136
Pubmed	Clinicopathologic features and BRCA mutations in primary fallopian tube cancer in Japanese women.	BRCA1 BRCA2	7.38e-06	2	95	2	29982601
Pubmed	Breast cancer detection and tumor characteristics in BRCA1 and BRCA2 mutation carriers.	BRCA1 BRCA2	7.38e-06	2	95	2	28343309
Pubmed	BRCA1 and BRCA2 genetic testing in Hispanic patients: mutation prevalence and evaluation of the BRCAPRO risk assessment model.	BRCA1 BRCA2	7.38e-06	2	95	2	17925560
Pubmed	Intratumor Heterogeneity of Homologous Recombination Deficiency in Primary Breast Cancer.	BRCA1 BRCA2	7.38e-06	2	95	2	27601588
Pubmed	Tamoxifen and risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers.	BRCA1 BRCA2	7.38e-06	2	95	2	23918944
Pubmed	Genomic Analysis of Circulating Tumor DNA in 3,334 Patients with Advanced Prostate Cancer Identifies Targetable BRCA Alterations and AR Resistance Mechanisms.	BRCA1 BRCA2	7.38e-06	2	95	2	33558422
Pubmed	Breast cancer risk associated with BRCA1/2 variants in the Pakistani population.	BRCA1 BRCA2	7.38e-06	2	95	2	30430339
Pubmed	Satisfaction with prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers is very high and little dependent on the participants' characteristics at surgery: a prospective study.	BRCA1 BRCA2	7.38e-06	2	95	2	33534430
Pubmed	BRCA 1, 2 mutation and earlier menopause: could BRCA 1,2 be used as predictor of menopause?	BRCA1 BRCA2	7.38e-06	2	95	2	34137566
Pubmed	BRCA1/2 Mutation Detection in the Tumor Tissue from Selected Polish Patients with Breast Cancer Using Next Generation Sequencing.	BRCA1 BRCA2	7.38e-06	2	95	2	33918338
Pubmed	Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.	BRCA1 BRCA2	7.38e-06	2	95	2	26181175
Pubmed	Mutational analysis of BRCA1 and BRCA2 in Mediterranean Spanish women with early-onset breast cancer: identification of three novel pathogenic mutations.	BRCA1 BRCA2	7.38e-06	2	95	2	14517958
Pubmed	Better life expectancy in women with BRCA2 compared with BRCA1 mutations is attributable to lower frequency and later onset of ovarian cancer.	BRCA1 BRCA2	7.38e-06	2	95	2	18559571
Pubmed	BRCA1-2 diagnostic workflow from next-generation sequencing technologies to variant identification and final report.	BRCA1 BRCA2	7.38e-06	2	95	2	27225819
Pubmed	BRCA1 and BRCA2 mutation prevalence and clinical characteristics of a population-based series of ovarian cancer cases from Denmark.	BRCA1 BRCA2	7.38e-06	2	95	2	18559594
Pubmed	Characterization of BRCA1 and BRCA2 genetic variants in a cohort of Bahraini breast cancer patients using next-generation sequencing.	BRCA1 BRCA2	7.38e-06	2	95	2	31131559
Pubmed	The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.	BRCA1 BRCA2	7.38e-06	2	95	2	11981002
Pubmed	Identification of twenty-nine novel germline unclassified variants of BRCA1 and BRCA2 genes in 1400 Italian individuals.	BRCA1 BRCA2	7.38e-06	2	95	2	29020660
Pubmed	An emerging entity: pancreatic adenocarcinoma associated with a known BRCA mutation: clinical descriptors, treatment implications, and future directions.	BRCA1 BRCA2	7.38e-06	2	95	2	21934105
Pubmed	Revertant mosaicism for family mutations is not observed in BRCA1/2 phenocopies.	BRCA1 BRCA2	7.38e-06	2	95	2	28199346
Pubmed	Results of a population-based screening for hereditary breast cancer in a region of North-Central Italy: contribution of BRCA1/2 germ-line mutations.	BRCA1 BRCA2	7.38e-06	2	95	2	18092194
Pubmed	Diet, lifestyle and BRCA-related breast cancer risk among French-Canadians.	BRCA1 BRCA2	7.38e-06	2	95	2	16541324
Pubmed	Investigating the relationship between BRCA1 and BRCA2 genes methylation profile and sperm DNA fragmentation in infertile men.	BRCA1 BRCA2	7.38e-06	2	95	2	31095775
Pubmed	Ethnic-specificity, evolution origin and deleteriousness of Asian BRCA variation revealed by over 7500 BRCA variants derived from Asian population.	BRCA1 BRCA2	7.38e-06	2	95	2	36385461
Pubmed	Screening for Genetic Testing in Breast Cancer - Are We Missing the Full Picture?	BRCA1 BRCA2	7.38e-06	2	95	2	26254840
Pubmed	Contribution of BRCA1 germ-line mutations to breast cancer in Greece: a hospital-based study of 987 unselected breast cancer cases.	BRCA1 BRCA2	7.38e-06	2	95	2	19491894
Pubmed	Young age at first pregnancy does protect against early onset breast cancer in BRCA1 and BRCA2 mutation carriers.	BRCA1 BRCA2	7.38e-06	2	95	2	29116468
Pubmed	BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study.	BRCA1 BRCA2	7.38e-06	2	95	2	26026974
Pubmed	Etiology of familial breast cancer with undetected BRCA1 and BRCA2 mutations: clinical implications.	BRCA1 BRCA2	7.38e-06	2	95	2	24306927
Pubmed	[Germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in China Han people].	BRCA1 BRCA2	7.38e-06	2	95	2	15059511
Pubmed	The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation.	BRCA1 BRCA2	7.38e-06	2	95	2	27880720
Pubmed	BRCA1 and BRCA2 mutations in Turkish familial and non-familial ovarian cancer patients: a high incidence of mutations in non-familial cases.	BRCA1 BRCA2	7.38e-06	2	95	2	12112655
Pubmed	Can soy phytoestrogens decrease DNA methylation in BRCA1 and BRCA2 oncosuppressor genes in breast cancer?	BRCA1 BRCA2	7.38e-06	2	95	2	22339411
Pubmed	Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants.	BRCA1 BRCA2	7.38e-06	2	95	2	34906479
Pubmed	Validation of Version 3.0 of the Breast Cancer Genetics Referral Screening Tool (B-RST™).	BRCA1 BRCA2	7.38e-06	2	95	2	29740170
Pubmed	Elevated expression of Ki-67 identifies aggressive prostate cancers but does not distinguish BRCA1 or BRCA2 mutation carriers.	BRCA1 BRCA2	7.38e-06	2	95	2	20043088
Pubmed	Utilization of breast cancer screening in a clinically based sample of women after BRCA1/2 testing.	BRCA1 BRCA2	7.38e-06	2	95	2	12376518
Pubmed	Characterization and in silico analyses of the BRCA1/2 variants identified in individuals with personal and/or family history of BRCA-related cancers.	BRCA1 BRCA2	7.38e-06	2	95	2	32599251
Pubmed	Oral contraceptive use and breast or ovarian cancer risk in BRCA1/2 carriers: a meta-analysis.	BRCA1 BRCA2	7.38e-06	2	95	2	20537530
Pubmed	Multiple founder effects and geographical clustering of BRCA1 and BRCA2 families in Finland.	BRCA1 BRCA2	7.38e-06	2	95	2	11039575
Pubmed	Germline and Somatic BRCA1/2 Gene Mutational Status and Clinical Outcomes in Epithelial Peritoneal, Ovarian, and Fallopian Tube Cancer: Over a Decade of Experience in a Single Institution in Korea.	BRCA1 BRCA2	7.38e-06	2	95	2	32718143
Pubmed	Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis.	BRCA1 BRCA2	7.38e-06	2	95	2	20309627
Pubmed	BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study.	BRCA1 BRCA2	7.38e-06	2	95	2	28549976
Pubmed	Next Generation Sequencing Reveals High Prevalence of BRCA1 and BRCA2 Variants of Unknown Significance in Early-Onset Breast Cancer in African American Women.	BRCA1 BRCA2	7.38e-06	2	95	2	28439188
Pubmed	BRCA1/2 test results impact risk management attitudes, intentions, and uptake.	BRCA1 BRCA2	7.38e-06	2	95	2	20383578
Pubmed	Assessment of ovarian reserve and reproductive outcomes in BRCA1 or BRCA2 mutation carriers.	BRCA1 BRCA2	7.38e-06	2	95	2	31780568
Interaction	YWHAZ interactions	BDP1 FNDC3B ARHGAP32 FZR1 BRCA1 DCP1B DOCK9 SH3D19 KCNMA1 ANKRD34A PAK2 TAB2 WDR5 MPHOSPH9 NEB SQOR DYNC1H1 LUZP1 GAB2	9.03e-06	1319	94	19	int:YWHAZ
Interaction	YWHAB interactions	ARHGAP32 PPP2R5D DCP1B RPS6KA1 DOCK9 SH3D19 DENND2C KCNMA1 ANKRD34A PAK2 MPHOSPH9 NEB DYNC1H1 LUZP1 GAB2 SRSF12	1.70e-05	1014	94	16	int:YWHAB
Interaction	ZYX interactions	CASS4 ARHGAP32 DCP1B SH3D19 HIPK2 TAB2 MPHOSPH9 RGS2 LUZP1	2.32e-05	329	94	9	int:ZYX
GeneFamily	Dyneins, cytoplasmic	DYNC2H1 DYNC1H1	9.09e-04	13	63	2	538
GeneFamily	Dyneins, axonemal	DNAI1 DNAH14	1.57e-03	17	63	2	536
GeneFamily	Ring finger proteins\|Fanconi anemia complementation groups\|Protein phosphatase 1 regulatory subunits\|BRCA1 A complex\|BRCA1 B complex\|BRCA1 C complex	BRCA1 BRCA2	2.18e-03	20	63	2	548
GeneFamily	G-patch domain containing\|Minor histocompatibility antigens	AGGF1 NKRF	2.64e-03	22	63	2	579
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3	BDP1 ARHGAP32 BRCA1 BRCA2 ICE2 HIPK2 CKAP2L MPHOSPH9 LUZP1	5.30e-06	291	93	9	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3
CoexpressionAtlas	FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4	BDP1 BRCA1 BRCA2 ICE2 PCLO MPHOSPH9 LUZP1	2.18e-05	192	93	7	Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2	BDP1 BRCA1 BRCA2 ICE2 CKAP2L MPHOSPH9 NKRF LUZP1	6.70e-05	311	93	8	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#5	BDP1 DNAI1 BRCA2 ICE2 CKAP2L MPHOSPH9 LUZP1 SRSF12	1.03e-04	331	93	8	Facebase_RNAseq_e10.5_Mandibular Arch_1000_K5
CoexpressionAtlas	dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#4_top-relative-expression-ranked_1000	CCDC117 SYCP2 BRCA2 ICE2 SYCP1	1.23e-04	110	93	5	gudmap_dev gonad_e13.5_M_GermCell_Oct_k4_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5	BDP1 BRCA2 ICE2 CKAP2L MPHOSPH9 LUZP1	1.69e-04	186	93	6	Facebase_RNAseq_e10.5_Mandibular Arch_500_K5
CoexpressionAtlas	dev gonad_e13.5_F_MeioticGermCell_Oct_k-means-cluster#1_top-relative-expression-ranked_100	SYCP2 SYCP1	1.88e-04	5	93	2	gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_k1_100
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#3	BDP1 BRCA1 BRCA2 DYNC2H1 MPHOSPH9 LUZP1	2.01e-04	192	93	6	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K3
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM SYCP2 XIRP2 PIK3C2G PCLO GRIN2B NEB	1.39e-07	184	95	7	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM SYCP2 XIRP2 PIK3C2G PCLO GRIN2B NEB	1.39e-07	184	95	7	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MGAM SYCP2 XIRP2 PIK3C2G PCLO GRIN2B NEB	1.39e-07	184	95	7	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Substantia_nigra-Neuronal\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	PCLO PEG3 ANKRD34A DISP2 GRIN2B GPRIN1 SRSF12	1.50e-07	186	95	7	3f889083fcffe516388e9b03a5e23af2010ced33
ToppCell	PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	CASS4 MGAM LPO GRIN2B PLEKHH2 SQOR	6.13e-07	142	95	6	191a13bba143ecdfc2bfd797c3ac191481388298
ToppCell	PBMC-Control-Myeloid-Neutrophil-Neutrophil-Neu_1\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	CASS4 MGAM LPO GRIN2B PLEKHH2 SQOR	6.39e-07	143	95	6	b405dba9a83a99cc7b53ce71772bc52a0bbb0d4e
ToppCell	human_hepatoblastoma-Tumor_cells-T6\|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)	CASS4 ABCC1 XIRP2 DLG2 GRIN2B HS3ST4	2.36e-06	179	95	6	14fc8ccb6b215063d747643f47d780d2b237eb67
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PIK3C2G DOCK9 SLC19A3 LAMA3 DLG2 DNAH14	3.44e-06	191	95	6	34cc997e4e5c727495f321e6807a84aa124da486
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	PIK3C2G DOCK9 SLC19A3 LAMA3 DLG2 DNAH14	3.54e-06	192	95	6	fb2f0e897228f808d9ff734ad05e9b49dc38fa50
ToppCell	mild-Myeloid-Neutrophils_1\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CASS4 MGAM NRBF2 TREM1 RGS2 GAB2	3.76e-06	194	95	6	ccd911ce3251cd1c60f1fb2ce00650fbe7a379bb
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAI1 DYNC2H1 FAM229B CFAP206 RP1 SPAG8	3.76e-06	194	95	6	a46238514bca920c3e3713d23c18ba24a09e2a29
ToppCell	mild-Myeloid-Neutrophils_3\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CASS4 MGAM NRBF2 TREM1 RGS2 GAB2	3.87e-06	195	95	6	a1cfed0092debcc003eff6a62508556b7664d5e1
ToppCell	Brain_organoid-organoid_Velasco_nature-6_mon-Neuronal-CPNs\|6_mon / Sample Type, Dataset, Time_group, and Cell type.	DOCK9 PCLO DLG2 DISP2 GRIN2B GPRIN1	3.99e-06	196	95	6	c9e7ac34993c873de4f198cdae77dcf099731532
ToppCell	IPF-Stromal-Myofibroblast\|Stromal / Disease state, Lineage and Cell class	CASS4 SH3D19 DLG2 LSAMP PLEKHH2 DNAH14	4.11e-06	197	95	6	f304d42fc4936fe20996e07c8dccc698a6e5e5ef
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer\|World / Primary Cells by Cluster	BDP1 DOCK9 PCLO DLG2 LSAMP GRIN2B	4.48e-06	200	95	6	db10f76938af553d1a2275bb02ef75dff3c3135b
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21\|World / Primary Cells by Cluster	BDP1 DOCK9 PCLO DLG2 LSAMP GRIN2B	4.48e-06	200	95	6	30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc
ToppCell	Control-Neu_1\|World / 5 Neutrophil clusters in COVID-19 patients	CASS4 LPO GRIN2B PLEKHH2 SQOR	1.17e-05	138	95	5	b7920c9a28d28220e7e4b30cd91ba13d0548eb76
ToppCell	PND01-Immune-Immune_Myeloid-Granulocytic\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MGAM SYCP2 PTPRC TREM1 IL1RL1	1.64e-05	148	95	5	74f1f9d1a53dc1a09cb6a504cbbdc7496c5b6879
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Myeloid\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CASS4 MGAM SYCP2 PTPRC TREM1	2.18e-05	157	95	5	320d5ac063fd90e26f537475c328b3ae73974bc1
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Myeloid-mast_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CASS4 MGAM SYCP2 PTPRC TREM1	2.18e-05	157	95	5	e4b17c267b754c5af95cdf17f629354d1a8a8ad7
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIK3C2G SYCP1 KCNMA1 GRIN2B PLEKHH2	2.39e-05	160	95	5	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIK3C2G SYCP1 KCNMA1 GRIN2B PLEKHH2	2.39e-05	160	95	5	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	facs-Lung-18m-Hematologic-myeloid-neutrophil\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MGAM SYCP2 PTPRC TREM1 RGS2	2.54e-05	162	95	5	ad974426039f4952c59d27167eac24dc6ce63f5e
ToppCell	facs-Lung-18m-Hematologic-myeloid-neutrophil-neutrophil\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MGAM SYCP2 PTPRC TREM1 RGS2	2.54e-05	162	95	5	4e7e565091bce227d794a36af2e5dfc4a791efad
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-Activated_CD8_T\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	DNAI1 PTPRC PTPN22 MPHOSPH9 SPAG8	2.69e-05	164	95	5	24fdea5113d92b96f56b06dd2449910a3c785e69
ToppCell	lung-Ciliated_Epithelia\|lung / shred on tissue and cell subclass	DNAI1 DYNC2H1 CFAP206 RP1 SPAG8	2.94e-05	167	95	5	26cf1cfa58ee74794449a87eb19cd896e1ec8892
ToppCell	LPS-IL1RA+antiTNF\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SH3D19 LAMA3 DLG2 LSAMP PLEKHH2	3.87e-05	177	95	5	b7fee75de7e96924af488a5baa2334711889ae7c
ToppCell	severe-Myeloid-Neutrophils_1\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CASS4 PTPRC TREM1 RGS2 GAB2	3.87e-05	177	95	5	d1ad35ee3d2a84b1d01126d0a38464ab858c00d0
ToppCell	facs-Brain_Non-Myeloid-Cortex_-18m-Neuronal-Granular_Neuron_CB_Gabra6\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PIK3C2G DENND2C PEG3 GPRIN1 CHRNA5	3.87e-05	177	95	5	9b02fd91c110b405eba6cb74ceb90b1286535973
ToppCell	LPS-antiTNF-Myeloid-Neutrophils-Neutrophils\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FNDC3B MGAM PTPRC TREM1 GAB2	3.98e-05	178	95	5	afcc92e8fe313c85eaf617cf4dbc3058da6c99d6
ToppCell	LPS-antiTNF-Myeloid-Neutrophils\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FNDC3B MGAM PTPRC TREM1 GAB2	3.98e-05	178	95	5	bd689205bc92cda5f71df64c2332ff76adcd84b4
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	BRCA1 BRCA2 LAMA3 CKAP2L CHRNA5	4.09e-05	179	95	5	88d44b04eb5c079531db663ed98ddb20b60feb9a
ToppCell	LPS-IL1RA-Myeloid-Neutrophils-Neutrophils\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FNDC3B MGAM PTPRC TREM1 GAB2	4.20e-05	180	95	5	c0c07937839652e01df10cc1e70aa005800ea6f6
ToppCell	LPS-IL1RA-Myeloid-Neutrophils\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FNDC3B MGAM PTPRC TREM1 GAB2	4.20e-05	180	95	5	079c199425dd3c220f03c6dca1823946f07580a1
ToppCell	severe-Myeloid-Neutrophils_1\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CASS4 PTPRC TREM1 RGS2 GAB2	4.54e-05	183	95	5	60a6112aa4fc4f5debda4c7e81b37539ba2e4e6e
ToppCell	mild-Myeloid-Neutrophils_1\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CASS4 PTPRC TREM1 RGS2 GAB2	4.66e-05	184	95	5	1a0e8b20b3ac8416d05c2d5934ab4ac80be4cce5
ToppCell	NS-moderate-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAI1 DYNC2H1 CFAP206 RP1 SPAG8	4.78e-05	185	95	5	5e689c2fb36ce3ac2adc8d15f67107f21cf68868
ToppCell	Ciliated_cells-B-Myositis-ILD_01\|World / lung cells shred on cell class, cell subclass, sample id	DNAI1 DYNC2H1 FAM229B CFAP206 RP1	4.78e-05	185	95	5	f012c243343e1d1956db19b34d062e9b13de2b2a
ToppCell	NS-critical-d_16-33-Epithelial-Ciliated\|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAI1 DYNC2H1 CFAP206 RP1 SPAG8	4.91e-05	186	95	5	76033438426d8f9c72cd6691a7baf92104c9f03d
ToppCell	18-Distal-Epithelial-Multiciliated_cell\|Distal / Age, Tissue, Lineage and Cell class	DNAI1 TREM1 CFAP206 RP1 SPAG8	5.03e-05	187	95	5	8d7fa6b2950898e7f283401808378ba2a41b9651
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SH3D19 TRIM55 KCNMA1 LAMA3 RP1	5.03e-05	187	95	5	87b3d0478693d4c54ff06b74e5903036b9c1ee6a
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SH3D19 TRIM55 KCNMA1 LAMA3 RP1	5.03e-05	187	95	5	42a1267bfc27b4460b8409ada580a87c4385841c
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SH3D19 TRIM55 KCNMA1 LAMA3 RP1	5.03e-05	187	95	5	64afdea159f5e67a1e5cea35ce898aae6e80aea5
ToppCell	multiciliated\|World / shred by cell class for bronchial biopsy	DNAI1 DYNC2H1 FAM229B CFAP206 SPAG8	5.16e-05	188	95	5	6833c1f0f265ef5448fa65033550ed7efc2f8d7b
ToppCell	21-Trachea-Epithelial-Multiciliated_cell\|Trachea / Age, Tissue, Lineage and Cell class	DNAI1 DYNC2H1 FAM229B RP1 SPAG8	5.16e-05	188	95	5	803bf76a85b3033d2a04b08dd2c03ce9c15529ba
ToppCell	(7)_Epithelial_cells-(7)_Epithelial-F_(Ciliated)\|(7)_Epithelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4)	DNAI1 DYNC2H1 FAM229B RP1 SPAG8	5.16e-05	188	95	5	5ba5cbb403518026e9040379fb5d99339ea977d8
ToppCell	343B-Epithelial_cells-Epithelial-F_(Ciliated)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DNAI1 DYNC2H1 FAM229B RP1 SPAG8	5.29e-05	189	95	5	57ab947b81dbd9d3e896be89e28c4a62cf720837
ToppCell	343B-Epithelial_cells-Epithelial-F_(Ciliated)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	DNAI1 DYNC2H1 FAM229B RP1 SPAG8	5.29e-05	189	95	5	ebc16b8eab84167d74446783d7e802acedc6b9c6
ToppCell	facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XIRP2 MYPN TRIM55 OSBP2 RP1	5.29e-05	189	95	5	e758b264c0a47127e33e66c395cf5a3224c7305b
ToppCell	facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	XIRP2 MYPN TRIM55 OSBP2 RP1	5.29e-05	189	95	5	b98f60875b1a12b2ec9dc91889298ae57f98602f
ToppCell	mild-Others\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	FSTL1 TREM1 OSBP2 RGS2 GAB2	5.43e-05	190	95	5	782dc1b612ac1faad7cc2781bfda92a079830d38
ToppCell	343B-Epithelial_cells-Epithelial-F_(Ciliated)\|343B / Donor, Lineage, Cell class and subclass (all cells)	DNAI1 DYNC2H1 FAM229B RP1 SPAG8	5.43e-05	190	95	5	169e600e95878000acf5d11f813f9028c7249646
ToppCell	343B-Epithelial_cells-Epithelial-F_(Ciliated)-\|343B / Donor, Lineage, Cell class and subclass (all cells)	DNAI1 DYNC2H1 FAM229B RP1 SPAG8	5.43e-05	190	95	5	0cc36117c793d83cf4a1f66f47758a07d6712bd3
ToppCell	Control-Myeloid-Transitioning_MDM\|Control / group, cell type (main and fine annotations)	MGAM PTPRC KCNMA1 RGS2 GAB2	5.43e-05	190	95	5	d6fd8c23cde4a10cc1517b6899a5a855fdfff2e2
ToppCell	droplet-Heart-nan-3m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FSTL1 XIRP2 SH3D19 PEG3 LSAMP	5.43e-05	190	95	5	96a92212ea3fb35fa3d0da495e504edc61c71c23
ToppCell	mild-Others-Megakaryocytes\|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	FSTL1 TREM1 OSBP2 RGS2 GAB2	5.56e-05	191	95	5	0b36223bd7f5758cc37194da6cc252f613bc3c97
ToppCell	Posterior_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Calb1-Excitatory_Neuron.Sc17a7.Calb1-Ddit4l_(Neurofilament,_Layer4?)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	XIRP2 TRIM55 CFAP206	5.68e-05	35	95	3	afb8cd52dffd630ffe8e7812874d5fd52e0b6752
ToppCell	Control-Lymphoid-T\|World / Disease state, Lineage and Cell class	CASS4 ABCC1 PTPRC PTPN22 LUZP1	5.70e-05	192	95	5	253cf4d2cf88ad8c45b73779336180840bef054b
ToppCell	multiciliated\|World / shred by cell class for turbinate	DNAI1 DYNC2H1 FAM229B RP1 SPAG8	5.70e-05	192	95	5	0f89ea0deb651ca11531c51ee94e0233608d22ea
ToppCell	IPF-Epithelial-Ciliated\|World / Disease state, Lineage and Cell class	DNAI1 DYNC2H1 FAM229B RP1 SPAG8	5.70e-05	192	95	5	d903bbd6c18e29e2c4cdedeb3fea1fd5ad7baa11
ToppCell	15-Trachea-Epithelial-Multiciliated_cell\|Trachea / Age, Tissue, Lineage and Cell class	DNAI1 DYNC2H1 FAM229B RP1 SPAG8	5.84e-05	193	95	5	aa3acc7571405169efb656d214f3a8cbf988362e
ToppCell	droplet-Pancreas-Endocrine-21m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TIA1 PCLO PEG3 DISP2 NEB	5.84e-05	193	95	5	471e65f02937bc18d7c5facdacdf1df58cf0f839
ToppCell	COPD-Myeloid\|COPD / Disease state, Lineage and Cell class	FNDC3B TREM1 KCNMA1 LSAMP GAB2	5.84e-05	193	95	5	f58552e286aa27e592497ad78776f58f8ee09841
ToppCell	Posterior_cortex-Neuronal\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	ANKRD34A DISP2 SLITRK3 GRIN2B GPRIN1	5.84e-05	193	95	5	b4989e3436e84dbec3789b46057e0f7a0ebf09d4
ToppCell	nucseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD4_T\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	CASS4 ABCC1 PTPRC PTPN22 LUZP1	5.84e-05	193	95	5	9c9434a3297b85774b4f0ecab6294f44d738e29f
ToppCell	Hippocampus-Neuronal\|Hippocampus / BrainAtlas - Mouse McCarroll V32	PCLO ANKRD34A DLG2 DISP2 GRIN2B	5.99e-05	194	95	5	8aeb347b3024354c9505f4f0fddf0b843489dc6b
ToppCell	NS-critical-d_07-13-Epithelial-Ciliated\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAI1 DYNC2H1 CFAP206 RP1 SPAG8	5.99e-05	194	95	5	1ae8a10e508e672e6677f0e3c986ac30d05adeb3
ToppCell	cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAI1 DYNC2H1 FAM229B RP1 SPAG8	6.14e-05	195	95	5	d8bf15aa7cdbc5f29b58e1e6cff76c257f0ea12e
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAI1 DYNC2H1 FAM229B RP1 SPAG8	6.14e-05	195	95	5	0e763f36786515698b593e5c93f6a56619c1242d
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAI1 DYNC2H1 FAM229B RP1 SPAG8	6.14e-05	195	95	5	581b04220587e1d5198b1abd6965965ace7803e7
ToppCell	3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAI1 DYNC2H1 FAM229B RP1 SPAG8	6.14e-05	195	95	5	93b1559382a12cfb158aa5fac7386e38b4f87989
ToppCell	CF-Myeloid\|CF / Disease state, Lineage and Cell class	FNDC3B PTPRC TREM1 RGS2 GAB2	6.14e-05	195	95	5	ecf604de496f389a49429d0bb211e1db6019cc8b
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MIA3 DYNC2H1 PCLO PEG3 DYNC1H1	6.14e-05	195	95	5	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	Macrophages-Donor_02\|World / lung cells shred on cell class, cell subclass, sample id	PTPRC SLC19A3 TREM1 LSAMP PTPN22	6.14e-05	195	95	5	2af46e87947c16a7c2c367637e606cfbb8a78528
ToppCell	5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAI1 DYNC2H1 FAM229B CFAP206 SPAG8	6.14e-05	195	95	5	e22ca35bea06aa95ff2cc771632969f5e7229ffc
ToppCell	Control-Myeloid\|Control / Disease state, Lineage and Cell class	FNDC3B TREM1 KCNMA1 HIPK2 GAB2	6.14e-05	195	95	5	46ce2e403ca5d757e5ba17349b6c7ce5cde1f195
ToppCell	BL-critical-LOC-Epithelial-Ciliated\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAI1 DYNC2H1 FAM229B RP1 SPAG8	6.14e-05	195	95	5	07a6bcef6af93ed87df455dee624037cb75e011a
ToppCell	cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Ciliated\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	DNAI1 DYNC2H1 FAM229B RP1 SPAG8	6.14e-05	195	95	5	e7f069f557a59ee7b502ff82ad4c9f47fa619ba8
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MIA3 DYNC2H1 PCLO PEG3 DYNC1H1	6.14e-05	195	95	5	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAI1 DYNC2H1 FAM229B CFAP206 SPAG8	6.29e-05	196	95	5	a37ba02446eef5d1fab703204583f6550a8ec3e1
ToppCell	COVID-19-Epithelial-Ciliated_cells\|Epithelial / Condition, Lineage and Cell class	DNAI1 DYNC2H1 FAM229B RP1 SPAG8	6.29e-05	196	95	5	de7aa31354b019d7321a8ef965d59ce2e8b89276
ToppCell	3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAI1 DYNC2H1 FAM229B CFAP206 SPAG8	6.29e-05	196	95	5	a156840330630e518bc85633dded6f2c3ead3b30
ToppCell	3'-Distal_airway-Epithelial-Airway_ciliated\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAI1 DYNC2H1 FAM229B CFAP206 SPAG8	6.29e-05	196	95	5	009e83c7251cf300be78b263634d233a8d972a68
ToppCell	BL-critical-LOC-Myeloid-Neutrophil\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FNDC3B MGAM PTPRC TREM1 RGS2	6.29e-05	196	95	5	f64d7fed31e418c55fe946744d78c3cbecec9bbf
ToppCell	mild-Myeloid-Neutrophils_3\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	CASS4 MGAM NRBF2 TREM1 RGS2	6.29e-05	196	95	5	9c351306b6aae68ed47d4cb1911957bf67f9e1ae
ToppCell	3'-Distal_airway-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DNAI1 DYNC2H1 FAM229B CFAP206 SPAG8	6.29e-05	196	95	5	89ea4d2086e1c769c5a87f1471a6cd4acabcfe33
ToppCell	NS-control-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAI1 DYNC2H1 FAM229B RP1 SPAG8	6.29e-05	196	95	5	d46ab80554dd3c1cc81e1938ea2acfd5e85c6d2a
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area\|World / Primary Cells by Cluster	DOCK9 PCLO KCNMA1 GRIN2B HS3ST4	6.44e-05	197	95	5	79b9e7f2e8e33b3c547f716be5667156c48b0dfc
ToppCell	NS-moderate-d_0-4-Epithelial-Ciliated\|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	DNAI1 DYNC2H1 FAM229B RP1 SPAG8	6.44e-05	197	95	5	71fea4aa6ce96c7693fa94792d08770622873850
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33\|World / Primary Cells by Cluster	DOCK9 PCLO KCNMA1 GRIN2B HS3ST4	6.44e-05	197	95	5	d20f29088e9afd8a960d6f680075c380e550f8a7
ToppCell	COVID-19-Fibroblasts\|COVID-19 / group, cell type (main and fine annotations)	FSTL1 SH3D19 DLG2 LSAMP PLEKHH2	6.44e-05	197	95	5	fb847f2277609c31fffcdf49517243ce0684facf
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PTPRC SLC19A3 TREM1 KCNMA1 LSAMP	6.60e-05	198	95	5	e125eb8aa57c172e5518874da1bd25998292f5e2
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alveolar\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PTPRC SLC19A3 TREM1 KCNMA1 LSAMP	6.60e-05	198	95	5	0baeb8e2c199ff10bb5c829c523546af3c9227c1
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	ARHGAP32 PCLO PEG3 KCNMA1 GRIN2B	6.60e-05	198	95	5	8ab40fae14fe02e39bc8c8da187a5cd60c787643
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV-2\|World / Primary Cells by Cluster	BDP1 PCLO DLG2 LSAMP GRIN2B	6.75e-05	199	95	5	f09b40245d3d826275bbe5f508dedccc75a911bd
ToppCell	mild-Neutrophil\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MGAM SYCP2 TREM1 IL1RL1 RGS2	6.75e-05	199	95	5	2fd5759acf49c02c5bbcc2941676216e7444d76d
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Layer_IV\|World / Primary Cells by Cluster	BDP1 PCLO DLG2 LSAMP GRIN2B	6.75e-05	199	95	5	e45448ec4db8875c8aaa9aad109a10e2905a4226
ToppCell	mild-Neutrophil\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MGAM SYCP2 TREM1 IL1RL1 RGS2	6.75e-05	199	95	5	ca319976a7d2576186d0a98cdc93e4c2d5fe8a05
ToppCell	Frontal_cortex-Neuronal\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	PCLO PEG3 DISP2 GRIN2B GPRIN1	6.75e-05	199	95	5	f88039d862f3bfa01dc39d2de4f3f548dc5a0e61
ToppCell	Control-Control-Myeloid-Neutrophil\|Control / Disease, condition lineage and cell class	MGAM LPO TREM1 RGS2 GAB2	6.92e-05	200	95	5	95c41f147a1594d49e73cb56d86d301c3115ce20
Disease	ductal carcinoma in situ (biomarker_via_orthology)	BRCA1 BRCA2	9.20e-06	2	90	2	DOID:0060074 (biomarker_via_orthology)
Disease	Hereditary site-specific ovarian cancer syndrome	BRCA1 BRCA2	9.20e-06	2	90	2	C4749652
Disease	Hereditary breast ovarian cancer syndrome	BRCA1 BRCA2	5.50e-05	4	90	2	cv:C0677776
Disease	hereditary breast ovarian cancer syndrome (is_implicated_in)	BRCA1 BRCA2	9.15e-05	5	90	2	DOID:5683 (is_implicated_in)
Disease	small cell lung carcinoma	BRCA2 DYNC2H1 PIWIL4 CHRNA5	1.07e-04	80	90	4	EFO_0000702
Disease	Adult only	BRCA1 BRCA2	1.37e-04	6	90	2	C3842001
Disease	Nemaline Myopathy, Childhood Onset	MYPN NEB	1.91e-04	7	90	2	C0546125
Disease	grapefruit juice consumption measurement	DCP1B PCLO	1.91e-04	7	90	2	EFO_0010094
Disease	ductal carcinoma in situ (is_implicated_in)	BRCA2 PAK2	1.91e-04	7	90	2	DOID:0060074 (is_implicated_in)
Disease	parasitemia measurement	MYPN LSAMP HS3ST4	1.98e-04	37	90	3	EFO_0005528
Disease	Bell's palsy	FNDC3B MGAM KCNMA1 LUZP1	2.74e-04	102	90	4	EFO_0007167
Disease	response to methylphenidate	LSAMP SQOR	3.27e-04	9	90	2	GO_0036271
Disease	Pancreatic carcinoma, familial	BRCA1 BRCA2	3.27e-04	9	90	2	C2931038
Disease	esophagus squamous cell carcinoma (is_implicated_in)	BRCA1 BRCA2 CHRNA5	3.55e-04	45	90	3	DOID:3748 (is_implicated_in)
Disease	Schizophrenia	ARHGAP32 FSTL1 BRCA1 TREM1 PAK2 DLG2 LSAMP GRIN2B RGS2 CHRNA5	3.61e-04	883	90	10	C0036341
Disease	Fanconi anemia (is_implicated_in)	BRCA1 BRCA2	4.07e-04	10	90	2	DOID:13636 (is_implicated_in)
Disease	Oligospermia	NR0B1 PIWIL4	5.95e-04	12	90	2	C0028960
Disease	Benign tumor of pancreas	BRCA1 BRCA2	7.02e-04	13	90	2	C0347284
Disease	creatine kinase measurement	MYPN NEB GAB2	7.88e-04	59	90	3	EFO_0004534
Disease	Hereditary Breast and Ovarian Cancer Syndrome	BRCA1 BRCA2	8.17e-04	14	90	2	C0677776
Disease	nasopharynx carcinoma (is_implicated_in)	BRCA1 CHRNA5	9.41e-04	15	90	2	DOID:9261 (is_implicated_in)
Disease	Spermatogenic Failure, Nonobstructive, Y-Linked	CDY2A CDY1	1.07e-03	16	90	2	C1839071
Disease	Spermatogenic failure, Y-linked, 2	CDY2A CDY1	1.07e-03	16	90	2	cv:C1839071
Disease	SPERMATOGENIC FAILURE, Y-LINKED, 2	CDY2A CDY1	1.07e-03	16	90	2	415000
Disease	hemoglobin A1 measurement	FNDC3B ABCC1 MGAM FZR1 RPS6KA1 PAK2 GAB2	1.07e-03	520	90	7	EFO_0007629
Disease	chronic obstructive pulmonary disease	FNDC3B RANBP10 MYPN DLG2 IL1RL1 MPHOSPH9 CHRNA5 GAB2	1.21e-03	688	90	8	EFO_0000341
Disease	Pancreatic carcinoma	BRCA1 BRCA2	1.52e-03	19	90	2	C0235974
Disease	Malignant neoplasm of breast	FNDC3B ABCC1 PTPRC BRCA1 BRCA2 DYNC2H1 TREM1 ANKRD34A DTX3L RGS2	1.61e-03	1074	90	10	C0006142
Disease	susceptibility to strep throat measurement	PCLO LAMA3 IL1RL1	1.64e-03	76	90	3	EFO_0008408
Disease	Adenocarcinoma of prostate	BRCA1 BRCA2	1.69e-03	20	90	2	C0007112
Disease	BREAST CANCER	BRCA1 BRCA2	1.86e-03	21	90	2	114480
Disease	age at menarche	FNDC3B NRBF2 BRCA1 SKOR2 DLG2 OSBP2 GAB2	2.29e-03	594	90	7	EFO_0004703
Disease	body fat percentage, coronary artery disease	MIA3 DYNC2H1	2.43e-03	24	90	2	EFO_0001645, EFO_0007800
Disease	pallidum volume	DLG2 HS3ST4	2.64e-03	25	90	2	EFO_0006933
Disease	Fanconi Anemia	BRCA1 BRCA2	2.64e-03	25	90	2	C0015625
Disease	breast cancer (implicated_via_orthology)	BRCA1 BRCA2	2.64e-03	25	90	2	DOID:1612 (implicated_via_orthology)
Disease	refractive error, age at onset, Myopia	FNDC3B KCNMA1 DLG2 GRIN2B	2.93e-03	193	90	4	EFO_0004847, HP_0000545, MONDO_0004892

Protein segments in the cluster

Peptide	Gene	Start	Entry
NSTQNVYKIPPTTTK	TREM1	146	Q9NP99
TVYATTRKPPAQSSK	FAM229B	61	Q4G0N7
SCPQPLNETSYSKIA	BDP1	1796	A6H8Y1
TKNAPSLPSRTCYKT	AKAP2	751	Q9Y2D5
KPKPSSNTKNYTGES	CCDC117	221	Q8IWD4
TKANYSKNSPKTPVT	CDY1	86	Q9Y6F8
TKANYSKNSPKTPVT	CDY2A	86	Q9Y6F7
KPNIYDIPKATSSVS	CASS4	346	Q9NQ75
LQKKPSTEQPLYSSS	AZIN2	341	Q96A70
NSTPPPTQLSKIKYS	PPP2R5D	61	Q14738
SSSSSNSSKLPPVCY	BTBD3	36	Q9Y2F9
VDLQPYPTSSTKQSK	AGGF1	256	Q8N302
YNLKKPHSQPSFCSS	DNAI1	411	Q9UI46
SSSPEKILSPFSQKY	DMXL1	916	Q9Y485
SQCPALQTSSPYKQA	DISP2	1226	A7MBM2
SGTKKTRQYLNSPPS	ANKRD34A	151	Q69YU3
YIKPITKCESSTQTN	CFAP206	506	Q8IYR0
TKSKQNHSKYPAPSS	RANBP10	396	Q6VN20
ADSYSPNLPKSTTKA	PTPN22	321	Q9Y2R2
TKSVPKCTDPTYNEI	PIK3C2G	1381	O75747
YSQSKNIPLSQPATT	HIPK2	51	Q9H2X6
LNYTKGATSSKPETP	LAMA3	2501	Q16787
STPSQCTKRYVITNP	KCNMA1	1146	Q12791
PSQTSPTVTYDSNLK	MGAM	921	O43451
SGSTSNTPYTPLEKK	KIAA1109	1576	Q2LD37
QSPQYLSATSPPKDK	PCLO	3576	Q9Y6V0
YDSKKPSPCEFINTT	LPO	346	P22079
KSVSYEQCKPVSVTP	MPHOSPH9	931	Q99550
PKKCGPYISSVTSQS	INSIG2	11	Q9Y5U4
VPQPKHASQKTVYSS	ARHGAP32	1461	A7KAX9
SPSSDGKQKTVYQTL	OSBP2	766	Q969R2
TISSNPYENQKIPTK	PEG3	751	Q9GZU2
GQSPLSQKYSPSTEK	NRBF2	111	Q96F24
SQKYSPSTEKCLPEI	NRBF2	116	Q96F24
STDTEYSQPEQKLPK	PLEKHH2	676	Q8IVE3
YSQPEQKLPKTCSSS	PLEKHH2	681	Q8IVE3
SAKQTYAAPKAPEAT	NR0B1	86	P51843
QIACSPPYSSKTRSQ	SLC51A	281	Q86UW1
DSNTVKQKYLSFTPP	PAK2	131	Q13177
TSQKSSEYPISQNPE	BRCA1	1456	P38398
PKKITSSSAIYDNPN	DCP1B	181	Q8IZD4
SPYSLSPVSNKSQKL	FZR1	146	Q9UM11
CKTKVYPDNLPTTSV	GALNT1	106	Q10472
KKSIFPYSVSLPQSC	DYNC2H1	3961	Q8NCM8
TPPANYKSSCTIDVT	CHRNA5	161	P30532
TVSGSEKNSKIYCPT	IL1RL1	121	Q01638
CTFPPKSLDTTTQQK	ICE2	926	Q659A1
NSSYIPTKQFETCSK	DOCK9	601	Q9BZ29
ETAKSPATCYTNQSP	BRCA2	1646	P51587
SPSEPETKAEQKSNY	DTX3L	221	Q8TDB6
LNSPPSSIYKSSCTT	FNDC3B	206	Q53EP0
KKSVSPSASPVVCYQ	FSTL1	101	Q12841
SSLASSQEPEPKKYG	DENND2C	246	Q68D51
YFLPTKISTKTPNAS	DNAH14	3431	Q0VDD8
DNSCPNSKAPVLSKY	LUZP1	591	Q86V48
SNPNYDKTSAPITCE	DYNC1H1	1986	Q14204
NTPYGTASEPSEKAK	KCTD5	211	Q9NXV2
YEQKVSPVSASSPKE	KIAA1210	1306	Q9ULL0
PVYSTVNKLCDKPAS	DLG2	346	Q15700
KVDPLCSSKTYTVSP	GPRIN1	216	Q7Z2K8
CSSKTYTVSPRKEDP	GPRIN1	221	Q7Z2K8
TYSTKSQKDVQSPAP	SLC19A3	461	Q9BZV2
SDYTQTLSKKPEIPT	HS3ST4	296	Q9Y661
KAYSPKETCNPSDTF	RP1	1266	P56715
VYSSKDPAQPKESSK	ABCC1	276	P33527
NSPAPKKSTGSVDYL	GAB2	601	Q9UQC2
TTAPEKYRVKPSNSS	MOSPD2	366	Q8NHP6
SSIPIPSSNSTEKKY	TAS2R40	171	P59535
SYFLQNSSTPGKPKT	RGS2	46	P41220
NQTPTKKYDGYTSCP	SQOR	366	Q9Y6N5
ETKSSYIAASTAKPP	TRMT1L	211	Q7Z2T5
LKSPMPSSTTQKDSY	SPAG8	321	Q99932
KKSVSSENPTYPSAP	SH3D19	146	Q5HYK7
TQPNTKYTFKITVSP	TAB2	456	Q9NYJ8
PDSKQGKPQSATDYS	MIA3	421	Q5JRA6
NYPPTITESKSNEAT	LSAMP	216	Q13449
KTQPTYPSVKSSQCH	NKRF	411	O15226
ASSVEYKSSNKQPKP	SLITRK3	321	O94933
SIKKYLSSDCPVPSQ	PIWIL4	561	Q7Z3Z4
ARSPCKSPKGYTNSE	SRSF12	221	Q8WXF0
ECVSSNPYSKPSSKS	CKAP2L	106	Q8IYA6
NPYSKPSSKSFQQCE	CKAP2L	111	Q8IYA6
AKAFKSPLSSPQQTQ	CNOT11	331	Q9UKZ1
ESSPKQPTNPYASSK	TGDS	156	O95455
PTKNELSQSPKKDSY	XIRP2	2961	A4UGR9
YKGQTRKATTNPPCT	TRIM55	446	Q9BYV6
SDNPSPSSSRKVKSY	SRRM5	231	B3KS81
TSAKNTLSTPLPKAY	SYCP1	841	Q15431
DCITKSISPYPKTSS	SYCP2	1131	Q9BX26
PSLEEQPSYKDSQKT	SKOR2	861	Q2VWA4
VPQSSHSKEEPYKCS	ZNF445	751	P59923
QSSYPGDNTKPKTTE	ZNF543	76	Q08ER8
GTQTSPVPRKKTYQC	ZNF423	1156	Q2M1K9
TTPSKPTCDEKYANI	PTPRC	221	P08575
SSKIPAVTYPKNEST	TRMT10C	41	Q7L0Y3
SSATQSKPTPVKPNY	WDR5	21	P61964
PPAPKSTYESNTKQL	TIA1	186	P31483
TYSALNSSKPTPQLK	RPS6KA1	701	Q15418
TSSKESPQEAKRPQY	MYPN	126	Q86TC9
ASTTKYPQSPTNSKA	GRIN2B	1276	Q13224
EKTKGQPYASTTDTP	NEB	106	P20929